JP2010522137A5 - - Google Patents

Download PDF

Info

Publication number
JP2010522137A5
JP2010522137A5 JP2009540891A JP2009540891A JP2010522137A5 JP 2010522137 A5 JP2010522137 A5 JP 2010522137A5 JP 2009540891 A JP2009540891 A JP 2009540891A JP 2009540891 A JP2009540891 A JP 2009540891A JP 2010522137 A5 JP2010522137 A5 JP 2010522137A5
Authority
JP
Japan
Prior art keywords
composition
effective amount
risperidone
day
hydroxyrisperidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009540891A
Other languages
English (en)
Japanese (ja)
Other versions
JP4643742B2 (ja
JP2010522137A (ja
Filing date
Publication date
Priority claimed from US11/638,282 external-priority patent/US7645750B2/en
Application filed filed Critical
Publication of JP2010522137A publication Critical patent/JP2010522137A/ja
Publication of JP2010522137A5 publication Critical patent/JP2010522137A5/ja
Application granted granted Critical
Publication of JP4643742B2 publication Critical patent/JP4643742B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009540891A 2006-12-13 2007-11-27 ホルモン変化の症状を治療する又は予防するための方法 Expired - Fee Related JP4643742B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/638,282 US7645750B2 (en) 2006-12-13 2006-12-13 Method of treating symptoms of hormonal variations
PCT/IB2007/004514 WO2008087491A2 (en) 2006-12-13 2007-11-27 Method for treating or preventing symptoms of hormonal variations

Publications (3)

Publication Number Publication Date
JP2010522137A JP2010522137A (ja) 2010-07-01
JP2010522137A5 true JP2010522137A5 (enExample) 2010-08-26
JP4643742B2 JP4643742B2 (ja) 2011-03-02

Family

ID=39528142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540891A Expired - Fee Related JP4643742B2 (ja) 2006-12-13 2007-11-27 ホルモン変化の症状を治療する又は予防するための方法

Country Status (11)

Country Link
US (3) US7645750B2 (enExample)
EP (1) EP2101781B1 (enExample)
JP (1) JP4643742B2 (enExample)
KR (1) KR101435695B1 (enExample)
CN (2) CN102697785B (enExample)
AT (1) ATE506065T1 (enExample)
CA (1) CA2671954C (enExample)
DE (1) DE602007014102D1 (enExample)
MY (1) MY162095A (enExample)
TW (1) TWI330083B (enExample)
WO (1) WO2008087491A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527142A (en) 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US8631151B2 (en) 2006-05-18 2014-01-14 Intel Corporation Techniques for guaranteeing bandwidth with aggregate traffic
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2010513569A (ja) * 2006-12-19 2010-04-30 ユニバーシティ オブ バージニア パテント ファウンデーション アルコール摂取に対するトピラメートおよびオンダンセトロンの併用効果
WO2009029308A1 (en) * 2007-08-27 2009-03-05 University Of Virginia Patent Foundation Medication combinations for the treatment of alcoholism and drug addiction
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PL2255184T3 (pl) 2008-02-28 2013-12-31 Univ Virginia Patent Foundation Gen transportera serotoniny i leczenie alkoholizmu
WO2011109367A2 (en) * 2010-03-02 2011-09-09 Royster Jr George E Methods and compositions for treating or preventing symptoms of hormonal variations
US8461102B2 (en) 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
EP2588112B1 (en) * 2010-06-30 2017-09-27 Victoria Link Ltd Methods and compositions for treatment of multiple sclerosis
PL2801625T3 (pl) 2010-07-02 2018-06-29 University Of Virginia Patent Foundation Molekularne, genetyczne podejście do leczenia i diagnozy uzależnienia od alkoholu i leków
CN103596571A (zh) * 2011-05-10 2014-02-19 刘垂玗 用于治疗失眠的方法
EP3045173A3 (en) 2011-09-09 2016-09-14 The University of Virginia Patent Foundation Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
WO2015013285A2 (en) 2013-07-22 2015-01-29 Ohio State Innovation Foundation Methods for reducing the occurrence of hot flashes
SG11201708162UA (en) * 2015-04-07 2017-11-29 Meiji Co Ltd Hot flash-suppressing agent

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
FR2358892A1 (fr) * 1976-07-19 1978-02-17 Ile De France N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
WO1999020223A2 (en) * 1997-10-20 1999-04-29 Novo Nordisk A/S Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
FR2779579B1 (fr) * 1998-06-09 2000-08-25 Thomson Csf Dispositif de commande optique pour l'emission et la reception d'un radar large bande
ES2287021T3 (es) * 1999-07-22 2007-12-16 University Of Rochester Metodo para el tratamiento de sintomas de variacines hormonales que incluyen el fogaje.
US6613792B1 (en) * 1999-08-02 2003-09-02 Designed Nutritional Products, Inc. Treatment of premenstrual syndrome and menopause
AR025111A1 (es) * 1999-08-13 2002-11-06 Janus Pharmaceuticals Inc Metodos y composiciones para tratar trastornos de ansiedad generalizada
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
JP2004531506A (ja) * 2001-03-29 2004-10-14 ブリストル−マイヤーズ スクイブ カンパニー 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体
WO2003037334A1 (en) * 2001-10-31 2003-05-08 Merck & Co., Inc. Method for treating or preventing symptoms of hormonal variation including hot flashes
CN1465348A (zh) 2002-07-05 2004-01-07 复方消融合剂及其在用作制备治疗肿瘤药物上的应用
US20040127489A1 (en) * 2002-07-29 2004-07-01 David Pickar Novel antipsychotic combination therapies and compositions useful therein
JP2006500366A (ja) * 2002-08-15 2006-01-05 ワイス 温度調節機能障害の治療ための5HT2a受容体の拮抗
MXPA05005609A (es) * 2002-11-26 2005-07-26 Alexza Pharmaceuticals Inc Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion.
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
MXPA06013163A (es) * 2004-05-11 2007-02-13 Pfizer Prod Inc Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b.
CA2569411A1 (en) * 2004-06-04 2005-12-22 Mood Management Sciences, Llc Methods and compositions for treating mood disorder
TW200631584A (en) 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations

Similar Documents

Publication Publication Date Title
JP2010522137A5 (enExample)
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
HRP20210487T1 (hr) Farmaceutski sastavi koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
JP2009525343A5 (enExample)
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
IL278188B1 (en) Sublingual formulation of riluzole
HRP20150644T1 (hr) Metoda za lijeäśenje atrijalne fibrilacije
JP2016517434A5 (enExample)
AR062167A1 (es) Sistema de administracion gastrorretentivo
JP2017535613A5 (enExample)
CA2671954A1 (en) Methods for treating or preventing symptoms of hormonal variations
FI3710000T3 (fi) Tradipitantti käytettäväksi gastropareesin hoidossa
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
JP2024010018A (ja) うつ病を治療するための組成物および方法
JP2009517411A5 (enExample)
TW200946142A (en) Tablet
JP2009534367A5 (enExample)
WO2008120966A1 (es) Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.
JP2008088189A5 (enExample)
JP2010524906A5 (enExample)
RU2011113733A (ru) Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах
JP2012500248A (ja) 不安障害の治療
ES2678122T3 (es) Comprimidos bucales mucoadherentes para el tratamiento del herpes orofacial
CN100386071C (zh) 一种治疗咳喘、慢性支气管炎的药物
JP2013542262A5 (enExample)